ImmuCell

ImmuCell Market capitalization

The The market capitalization of ImmuCell (ICCC) as of Nov 22, 2026 is 59.70 M USD. In the previous year, The market capitalization was 59.70 M USD — a change of 0.00% (lower).

Market capitalization

59.70 MUSD

YoY

0.00%

Last updated:

In 2025, ImmuCell's market cap stood at 59.70 M USD, a 0.00% increase from the 59.70 M USD market cap in the previous year.

The ImmuCell Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
59.70 M USD
Jan 1, 2019
59.70 M USD
Jan 1, 2020
59.70 M USD
Jan 1, 2021
59.70 M USD
Jan 1, 2022
59.70 M USD
Jan 1, 2023
59.70 M USD
Jan 1, 2024
59.70 M USD
Jan 1, 2025
59.70 M USD
The ImmuCell Market capitalization history
YEARMarket capitalizationYoY
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD0.00%
59.70 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring ImmuCell's Market Capitalization

ImmuCell's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of ImmuCell's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

ImmuCell's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in ImmuCell’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about ImmuCell stock

The market capitalization of ImmuCell is 59.70 M USD in 2025.

The market capitalization of ImmuCell changed from 59.70 M USD to 59.70 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization ImmuCell since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's ImmuCell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — ImmuCell

All Key Metrics — ImmuCell